Drug Topics

JUNE 25, 2025

Taylor Watterson, PharmD, PhD, discusses how distress experienced by pharmacy technicians can impact the overall safety and quality of pharmacy operations.

Patient Care 216

Patient Care 216

Pharmacy Times

JUNE 25, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to

Immunization 50

Immunization Compounding Pharmacies Hospitals Compounding 50

Pharmaceutical Technology

JUNE 25, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

FDA 52

FDA Packaging Communication Hospitals 52

Pharmacy Times

JUNE 25, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to

Vaccines 50

Vaccines Compounding Pharmacies Immunization Specialty Pharmacies 50

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

The Checkup by Singlecare

JUNE 25, 2025

Wegovy (semaglutide) is a weekly injectable weight loss medication that’s a type of glucagon-like peptide-1 (GLP-1) receptor agonist. It contains semaglutide, the same active ingredient found in the Type 2 diabetes drug Ozempic. Although semaglutide was originally developed to regulate blood sugar, it has proven effective for weight loss as well, which led to the popularity of Ozempic and Wegovy, resulting in a nationwide shortage.

Insurance Coverage 52

Insurance Coverage Insurance FDA Labelling 52

Pharmacy Times

JUNE 25, 2025

A pharmacist-led program effectively reduces incorrect penicillin allergy labels, promoting better antibiotic use and enhancing patient care in intensive care units.

Labelling 118

Labelling Patient Care 118

Pharmacy Times

JUNE 25, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to

Compounding Pharmacies 65

Compounding Pharmacies Immunization Hospitals Compounding 65

Drug Topics

JUNE 25, 2025

News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy Journal Submission of Articles Events Virtual Events Total Pharmacy Solutions Summit Business Business Strategies Patient Services Pharmacy Inv

Vaccines 387

Vaccines Immunization Independent Pharmacies Compounding 387

Pharmacy Times

JUNE 25, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to

Chemotherapy 50

Chemotherapy Compounding Pharmacies Immunization Compounding 50

Drug Topics

JUNE 25, 2025

News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy Journal Submission of Articles Events Virtual Events Total Pharmacy Solutions Summit Business Business Strategies Patient Services Pharmacy Inv

Insurance Coverage 380

Insurance Coverage Insurance Compounding Prescription Filling 380

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmafile

JUNE 25, 2025

Roche has announced encouraging early results from its phase 1/2 trial of NXT007, an investigational bispecific antibody for haemophilia A. Data presented at the 2025 International Society on Thrombosis and Haemostasis Congress on 21 to 25 June, Washington DC, US, indicates that NXT007 may offer haemostatic normalisation in patients (without factor VIII inhibitors).

64

64

PharmaVoice

JUNE 25, 2025

Skip to main content CONTINUE TO SITE ➞ Dont miss the most important voices in pharma Let PharmaVoices free newsletter keep you informed on what industry leaders are saying, straight from your inbox. By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime. Voices Q&A Profiles Biotech Spotlight First 90 Days Opinions Topics Biotech Commercialization Leadership Manufacturing Patient Pharma Policy & Regulation Research & Deve

FDA 262

FDA Packaging Immunization 262

The Checkup by Singlecare

JUNE 25, 2025

Buprenorphine is a synthetic opioid medication approved by the Food and Drug Administration (FDA) to treat acute or chronic pain and opioid addiction. It’s a controlled substance and is available only by prescription. It’s sold as a generic medication and under several brand names in different formulations, including Belbuca and Butrans. Although most insurance plans cover medications for opioid use disorder (OUD) to some degree, that coverage varies by formulation and dosage.

Insurance 52

Insurance Dosage Insurance Coverage Controlled Substances 52

Pharmaceutical Commerce

JUNE 25, 2025

A panel of industry leaders emphasize the importance of early engagement with payers, real-world evidence, and value-based endpoints to ensure successful access, pricing, and long-term market viability—especially in a more complex, globally integrated reimbursement landscape.

52

52

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

The Checkup by Singlecare

JUNE 25, 2025

Asthma and chronic obstructive pulmonary disease (COPD) affect hundreds of millions of people, but the good news is that there are safe, effective treatments to help them breathe easily. One example is Breo Ellipta (fluticasone furoate/vilanterol), an inhalation powder approved by the Food and Drug Administration (FDA) as a once-daily maintenance treatment (not a rescue inhaler) for COPD and asthma.

Insurance 52

Insurance Dosage FDA 52

Drug Topics

JUNE 25, 2025

News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy Journal Submission of Articles Events Virtual Events Total Pharmacy Solutions Summit Business Business Strategies Patient Services Pharmacy Inv

Specialty Pharmacies 329

Specialty Pharmacies Compounding Independent Pharmacies Immunization 329

The Checkup by Singlecare

JUNE 25, 2025

Simvastatin (generic Zocor ) is an oral medication approved by the Food and Drug Administration (FDA) to lower cholesterol levels. This statin is generally safe and effective in treating high cholesterol, but taking it with certain other medications, drinks, or foods may increase the risk of serious side effects like liver or muscle damage. It is important to be aware of these interactions and tell your healthcare provider and pharmacist about all of the prescriptions and supplements you’re taki

Compounding 52

Compounding Labelling Hospitals FDA 52

Pharmaceutical Technology

JUNE 25, 2025

The US FDA has approved GSK's 200 mg/ml autoinjector of Benlysta for individuals aged five years and above with active lupus nephritis.

FDA 52

FDA 52

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

The Checkup by Singlecare

JUNE 25, 2025

Blood thinners can be life-saving medicines—and that’s no exaggeration. They significantly decrease the risk of blood clots, helping prevent heart attacks, strokes, pulmonary embolism, clogged blood vessels, deep vein thrombosis (DVT), and more. So for people prone to clotting, it’s vital to take them regularly and in the correct dosage. What happens, however, if you accidentally take more than directed?

Dosage 86

Dosage 86

Pharmacy Times

JUNE 25, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to

Compounding Pharmacies 50

Compounding Pharmacies FDA Immunization Compounding 50

The Checkup by Singlecare

JUNE 25, 2025

You’ve probably heard about Ozempic (semaglutide), the “miracle” drug that helps people with Type 2 diabetes control their blood sugar and lose significant amounts of weight. But you may not have heard of Mounjaro , another Type 2 diabetes medication, but with a different active ingredient (tirzepatide). Due to Ozempic’s newsworthy shortages and a growing demand for more GLP-1 drugs, people started talking about Mounjaro in 2022, when it was approved by the Food and Drug Administration (FDA) for

Insurance 52

Insurance Dosage FDA Labelling 52

Pharmaceutical Technology

JUNE 25, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

Packaging 52

Packaging Communication Hospitals Insurance 52

The Checkup by Singlecare

JUNE 25, 2025

Benazepril is a common angiotensin-converting enzyme inhibitor ( ACE inhibitor ). It’s used to decrease high blood pressure, a condition that, when untreated, can damage the heart and arteries, increasing your risk of stroke, heart attacks, heart failure, kidney disease, and kidney failure. Also sold under the brand name Lotensin , it works by blocking a chemical that makes your blood vessels tighten.

Dosage 81

Dosage Hospitals FDA 81

Drug Topics

JUNE 25, 2025

News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy Journal Submission of Articles Events Virtual Events Total Pharmacy Solutions Summit Business Business Strategies Patient Services Pharmacy Inv

Compounding 363

Compounding Specialty Pharmacies Independent Pharmacies Insurance 363

PharmTech

JUNE 25, 2025

Cambridge Healthcare Innovations says its dry powder inhaler engine, Quattrii, can deliver large volumes of biologic and mRNA molecules in a single inhalation.

59

59

Pharmacy Times

JUNE 25, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to

Compounding Pharmacies 65

Compounding Pharmacies Immunization Specialty Pharmacies Compounding 65

Pharmaceutical Technology

JUNE 25, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

Labelling 52

Labelling Packaging Communication FDA 52

Pharmacy Times

JUNE 25, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to

Compounding Pharmacies 73

Compounding Pharmacies Immunization Chemotherapy Compounding 73

Med Ed 101

JUNE 25, 2025

When comparing venlafaxine versus desvenlafaxine, we must first recognize that they are both part of the drug class called SNRIs. Both of these medications work by inhibiting the reuptake of both serotonin and norepinephrine. Venlafaxine comes in an extended-release capsule formulation, as well as an immediate and extended-release tablet formulation.

52

52

The Checkup by Singlecare

JUNE 25, 2025

Tamiflu (oseltamivir) is a prescription antiviral medication used to treat influenza (the flu) in people two weeks of age and older who ideally have had flu symptoms for no more than two days. Healthcare providers also prescribe the medication to reduce the chance of getting the virus in high-risk individuals exposed to the virus. Tamiflu is not currently available as an over-the-counter medicine; however, alternatives, such as pain relievers, decongestants, and cough suppressants, may offer sym

52

52

Drug Topics

JUNE 25, 2025

News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy Journal Submission of Articles Events Virtual Events Total Pharmacy Solutions Summit Business Business Strategies Patient Services Pharmacy Inv

Insurance Coverage 346

Insurance Coverage Insurance Compounding Specialty Pharmacies 346

Pharmaceutical Technology

JUNE 25, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

Packaging 52

Packaging Communication Hospitals Insurance 52

The Guardian - Pharmaceutical Industry

JUNE 25, 2025

Plaintiff says company’s bid to exit bankruptcy omits US government plan to seize $225m that should go to victims A New York bankruptcy judge approved a disclosure statement last week laying out Purdue Pharma’s proposed reorganization plan – despite an objection alleging the disclosure omits information about the US government’s plan to seize Purdue money that could be used to compensate prescription opioid victims under the Mandatory Victims Restitution Act instead.

60

60